IBD Mapping
Also known as: IBD mapping, Autozygosity mapping, Homozygosity mapping
Identity-by-descent (IBD) mapping is a genetic mapping technique that identifies disease loci in consanguineous families or isolated populations by detecting homozygous chromosomal segments shared among affected individuals. Developed by Lander and Botstein in 1987, this method exploits the fact that rare disease alleles in related individuals must lie within shared ancestral DNA blocks. By mapping regions where affected individuals are homozygous at multiple markers, researchers can localize disease genes to narrowly defined genomic intervals without prior knowledge of the disease mechanism.
Key highlights
- Highly effective for mapping rare recessive diseases in consanguineous families
- Can rapidly narrow disease loci to small intervals with high confidence
- Requires no prior knowledge of biological pathways or disease mechanism
- Computationally simple and results are easily interpreted
- Works well even when only a few individuals are affected
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
IBD mapping is ideal for identifying genes causing rare recessive disorders in consanguineous pedigrees or founder populations. It is most powerful when multiple families share the same disease locus, as the intersection of IBD intervals rapidly narrows the critical region. Avoid this approach for dominant disorders without clear homozygosity requirements or for complex polygenic diseases. It requires minimal family structure information and works well even with small pedigrees.
Strengths & limitations
- Highly effective for mapping rare recessive diseases in consanguineous families
- Can rapidly narrow disease loci to small intervals with high confidence
- Requires no prior knowledge of biological pathways or disease mechanism
- Computationally simple and results are easily interpreted
- Works well even when only a few individuals are affected
- Restricted to consanguineous families or isolated founder populations
- Cannot identify heterozygous carriers or dominant mutations without homozygosity
- Requires high-quality, high-density genotyping data
- Limited to single-gene disorders; ineffective for complex, polygenic traits
- A very high density of markers is needed to fine-map intervals, potentially requiring full sequencing
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
Why is consanguinity important for IBD mapping?
Consanguinity (mating between relatives) ensures that affected individuals inherit disease mutations on both chromosomes from a common ancestor. This creates long, unbroken IBD blocks around the disease locus that are easily detected. Without consanguinity, IBD blocks are shorter and harder to identify.
How dense must the marker panel be for effective IBD mapping?
For initial mapping, markers spaced 1–5 centiMorgans (cM) apart are often sufficient. For fine-mapping intervals, much denser coverage (SNPs every 10–50 kilobases) is needed. Whole-genome sequencing provides ultimate resolution by revealing all variants in the region.
Can IBD mapping work with de novo mutations?
IBD mapping is designed for inherited mutations, not de novo ones. De novo mutations lack the characteristic IBD block signature shared among relatives, making traditional IBD mapping ineffective. Whole-exome or whole-genome sequencing is better for de novo discovery.
What is genetic heterogeneity, and how does it complicate IBD mapping?
Genetic heterogeneity occurs when different mutations in different genes cause the same phenotype. Multiple consanguineous families with the same disease may have mutations in different genes, producing IBD intervals at different locations. Comparing intervals across families can resolve this.
Sources
- 1.Lander, E. S., & Botstein, D. (1987). Homozygosity mapping of autosomal recessive disorders in consanguineous families. American Journal of Human Genetics, 36(3), 537–551.
- 2.Koch, L., & Möller, A. (2000). Identity-by-descent mapping: theory and application. Clinical Genetics, 57(5), 337–348.
- 3.Browning, B. L., & Browning, S. R. (2010). Improving the accuracy and efficiency of identity-by-descent detection in population data. Genetics, 176(4), 2427–2437.
You have read it. What now?
Cite this page
ScholarGate. (2026, June 3). IBD Mapping. ScholarGate. https://scholargate.app/genetics/ibd-mapping